跳转至内容
Merck
CN

SML3881

Sigma-Aldrich

AK-2292

≥98% (HPLC)

别名:

((2-(((2S)-1-((2S)-2-((3-((5-(2-(2,6-Dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)pent-4-yn-1-yl)(methyl)amino)-3-oxopropyl)(4-(thiazol-2-yl)phenyl)carbamoyl)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)carbamoyl)benzo[b]thiophen-5-yl)difluoromethyl)phosphonic acid

登录查看公司和协议定价


About This Item

经验公式(希尔记法):
C52H54F2N7O10PS2
分子量:
1070.13
UNSPSC代码:
12352200
NACRES:
NA.77

质量水平

方案

≥98% (HPLC)

表单

powder

颜色

white to beige

溶解性

DMSO: 2 mg/mL, clear

储存温度

-10 to -25°C

生化/生理作用

Cell penetrant, potent and highly selective degrader of STAT5A and STAT5B isoforms.


AK-2292 is a cell penetrant, potent and highly selective PROTAC degrader of STAT5A (signal transducer and activator of transcription 5 A) and STAT5B isoforms. AK-2292 potently induces degradation of STAT5 in normal mouse tissues and human chronic myeloid leukemia (CML) xenografts in mice. It potently inhibits the growth of acute myeloid leukemia (AML) cell lines.

储存分类代码

11 - Combustible Solids

WGK

WGK 3

闪点(°F)

Not applicable

闪点(°C)

Not applicable

法规信息

新产品

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

A selective small-molecule STAT5 PROTAC degrader capable of achieving tumor regression in vivo
Atsunori Kaneshige
Nature Chemical Biology, 19(6), 703-711 (2023)
Discovery of a Potent and Selective STAT5 PROTAC Degrader with Strong Antitumor Activity In Vivo in Acute Myeloid Leukemia
Journal of medicinal chemistry, 66(4), 2717-2743 (2023)

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门